Pricing Policies in the Pharmaceutical Sector

被引：0
|
作者：
Stefano Capri
Rosella Levaggi
机构：
[1] ISIS Research,Dipartimento di Scienze Economiche
[2] Università di Brescia,undefined
来源：
Drug information journal : DIJ / Drug Information Association | 2002年 / 36卷
关键词：
Drug value; Price setting; Public health care expenditure;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
In this article we analyze the problem of determining the price for new drugs in a market where stringent budget constraints on public expenditure exists and we suggest an innovative methodology to set drug prices. The market is characterized by asymmetry of information and a high proportion of investment in research and development, an element that must be taken into account because it is only through research that it is possible to obtain better drugs.
引用
收藏
页码：453 / 464
页数：11
相关论文
共 50 条
  • [1] Pricing policies in the pharmaceutical sector
    Capri, S
    Levaggi, R
    [J]. DRUG INFORMATION JOURNAL, 2002, 36 (02): : 453 - 464
  • [2] Opportunities in pharmaceutical pricing policies
    Halpenny, Genevieve
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 251
  • [3] Pharmaceutical policies: effects of reference pricing, other pricing, and purchasing policies
    Acosta, Angela
    Ciapponi, Agustin
    Aaserud, Morten
    Vietto, Valeria
    Austvoll-Dahlgren, Astrid
    Koesters, Jan Peter
    Vacca, Claudia
    Machado, Manuel
    Hazbeydy Diaz Ayala, Diana
    Oxman, Andrew D.
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (10):
  • [4] Pharmaceutical policies:: effects of reference pricing, other pricing, and purchasing policies
    Aaserud, M.
    Dahlgren, A. T.
    Kosters, J. P.
    Oxman, A. D.
    Ramsay, C.
    Sturm, H.
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2006, (02):
  • [5] Challenges and opportunities for pharmaceutical pricing and reimbursement policies
    Sabine Vogler
    Nina Zimmermann
    Alessandra Ferrario
    Veronika J Wirtz
    Zaheer-Ud-Din Babar
    [J]. Journal of Pharmaceutical Policy and Practice, 8 (Suppl 1)
  • [6] Pricing policies for the pharmaceutical market - An international perspective
    Ilgin, Y
    Eisen, R
    [J]. VALUE IN HEALTH, 2005, 8 (06) : A184 - A184
  • [7] Pharmaceutical pricing and reimbursement policies: perspectives for the future
    Andrew L Gray
    [J]. Journal of Pharmaceutical Policy and Practice, 8 (Suppl 1)
  • [8] Incidence of public sector pricing policies in Pakistan
    Naqvi, ZF
    [J]. RESEARCH IN HUMAN CAPITAL AND DEVELOPMENT, VOL 11, PTS A AND B: MODELS FOR ECONOMIC POLICY EVALUATION THEORY AND PRACTICE: AN INTERNATIONAL EXPERIENCE, 1997, 11 : 469 - 493
  • [9] Mexican pharmaceutical pricing and reimbursement policies, OECD, 2007
    Moise, Pierre
    Docteur, Elizabeth
    [J]. SALUD PUBLICA DE MEXICO, 2008, 50 : S504 - S510
  • [10] Pharmaceutical pricing benchmarks: governmental versus private sector
    Turkistani, Fatema
    Bin Sawad, Aseel
    [J]. JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2020, 9 (15) : 1091 - 1100
12345